Kamin Peter 13D and 13G filings for Interpace Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-01 10:15 am Unchanged | 2022-01-28 | 13D | Interpace Biosciences, Inc. IDXG | Kamin Peter | 781,956 18.600% | 0 (Unchanged) | Filing |
| 2022-01-13 08:30 am Unchanged | 2022-01-12 | 13D | Interpace Biosciences, Inc. IDXG | Kamin Peter | 781,956 18.600% | 0 (Unchanged) | Filing |
| 2021-12-06 4:32 pm Unchanged | 2021-12-03 | 13D | Interpace Biosciences, Inc. IDXG | Kamin Peter | 781,956 18.700% | 0 (Unchanged) | Filing |
| 2021-03-01 4:06 pm Purchase | 2021-02-18 | 13D | Interpace Biosciences, Inc. IDXG | Kamin Peter | 781,956 19.300% | 781,956 (New Position) | Filing |